Related Experiment Video
Updated: Jul 6, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery
Gregorio Brevetti1, Federico Piscione, Plinio Cirillo
1Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples Federico II, Naples, Italy. brevetti@unina.it
Insights
Peripheral arterial disease (PAD) inflammation in affected limbs may worsen coronary artery disease (CAD) by impairing coronary artery endothelial function (CAEF). This suggests PAD mechanistically contributes to CAD progression.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Inflammation Research
Background:
- Concomitant peripheral arterial disease (PAD) in coronary artery disease (CAD) patients indicates more severe coronary atherosclerosis.
- The inflammatory status of affected limbs in PAD may impair coronary artery endothelial function (CAEF).
Purpose of the Study:
- To investigate if inflammation in affected limbs of PAD patients impacts CAEF.
- To determine if blood from PAD-affected limbs activates human coronary artery endothelial cells (HCAECs).
Main Methods:
- Measured neutrophil myeloperoxidase content (NMPOxC) and plasma interleukin-6/C-reactive protein in aorta, femoral vein, and coronary sinus of CAD+PAD and CAD-alone patients.
- Assessed CAEF using the cold pressure test and incubated HCAECs with patient serum.
- Analyzed transfemoral gradients of inflammatory markers and their correlation with CAEF.
Main Results:
- CAD+PAD patients showed higher NMPOxC and interleukin-6 across the femoral circulation compared to coronary circulation and healthy controls.
- Transfemoral gradients of NMPOxC and interleukin-6 correlated significantly with CAEF, especially post-exercise.
- Serum from PAD-affected limbs induced MCP-1 release from HCAECs in vitro.
Conclusions:
- Inflammatory triggers from PAD-affected circulation may activate endothelium at distant sites, impacting CAEF.
- PAD may play a mechanistic role in CAD progression, beyond being a cardiovascular risk marker.
Background:
In coronary artery disease (CAD), concomitant peripheral arterial disease (PAD) entails more severe coronary atherosclerosis. We investigated whether the inflammatory status of affected limbs impairs coronary artery endothelial function (CAEF).
Methods:
We measured the neutrophil myeloperoxidase content (NMPOxC) and plasma levels of interleukin-6 and C-reactive protein in the aorta, femoral vein, and coronary sinus of 22 CAD+PAD and 18 CAD-alone patients. CAEF was assessed by the cold pressure test. Human coronary artery endothelial cells (HCAECs) were incubated with serum from the femoral vein and aorta of CAD+PAD patients to determine whether blood leaving the affected limb activates HCAECs.
Results:
In CAD+PAD patients, NMPOxC was higher across the femoral circulation than across the coronary circulation (p<0.01); it was also higher than across healthy femoral circulation of CAD patients (p<0.01). These findings apply also to interleukin-6, but not to C-reactive protein. The transfemoral gradient of NMPOxC and interleukin-6 significantly correlated with CAEF. The NMPOxC/CAEF relationship was much greater after exercise (R=0.79, p<0.001), which increased neutrophil activation across the affected circulation. The post-exercise association remained significant after adjustment for potential confounders (p<0.01). Serum from the affected limb of CAD+PAD patients induced, in vitro, a significant release of MCP-1 from HCAECs versus serum from the aorta of the same patients (630 [550-740] vs. 547 [490-620]; p<0.05).
Conclusions:
In CAD+PAD, triggers from the affected circulation may activate the endothelium at distant sites. Thus, PAD, besides being a marker of cardiovascular risk, could exert a mechanistic function in CAD progression.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease IV: Nursing Management
Coronary Artery Disease II: Pathophysiology